Altamira Therapeutics

Altamira Therapeutics is dedicated to developing novel pharmaceutical therapies to protect hearing, silence tinnitus, and restore balance. Altamira Therapeutics is the leading pioneer in the emerging field of therapies for neurotologic disorders affecting the inner ear.

Oliver Kubli

Director

Alain Munoz Ph.D

Director

1 past transactions

Trasir Therapeutics

Acquisition in 2021
Trasir Therapeutics is a pioneer in extrahepatic oligonucleotide delivery. The company has developed an oligonucleotide delivery platform for delivery of short interfering RNA and other therapeutic RNA payloads to sites outside the liver.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.